StockNews.com initiated coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a research report report published on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
VBI Vaccines Price Performance
Shares of NASDAQ:VBIV opened at $0.02 on Friday. VBI Vaccines has a 52 week low of $0.06 and a 52 week high of $1.35. The company’s 50 day moving average is $0.49 and its two-hundred day moving average is $0.57.
VBI Vaccines Company Profile
Featured Stories
- Five stocks we like better than VBI Vaccines
- Using the MarketBeat Dividend Yield Calculator
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- What Makes a Stock a Good Dividend Stock?
- 2 Option Strategies to Maximize Profits in a Bear Market
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.